rethinkTHC Search
Menu
Study breakdown

Blocking the Brain's Endocannabinoid System Triggered a Full Stress Response in Rats, Even Without Any Stressor

Animal StudyModerate evidence
The takeaway

Disrupting endocannabinoid signaling in the brain with multiple different approaches all uniformly triggered stress hormone release, stress behaviors, and stress neuron activation, proving that the endocannabinoid system actively suppresses the stress response at rest.

Neuroscientists, anxiety researchers, stress biology researchers, cannabis pharmacologists.

Blocking endocannabinoids triggered full stress response even without any actual stressor

What the researchers found

CB1 receptor antagonist/inverse agonist AM251, neutral antagonist NESS243, and NAPE-PLD inhibitor LEI401 all uniformly increased PVN Fos expression, unmasked stress-linked behaviors (grooming), and increased circulating corticosterone, mimicking the effects of actual stress. Direct PVN administration of AM251 produced the same effects. Optogenetic inhibition of PVN CRH neurons ameliorated the behavioral changes, confirming these neurons mediate the effect.

Why it matters

This study provides definitive evidence that the endocannabinoid system is not just involved in stress modulation but actively restrains the stress response at all times. Without this constant endocannabinoid "brake," the body generates a full stress response even in the absence of any actual threat.

The numbers in context

Three different pharmacological approaches all produced uniform stress responses. Direct PVN administration confirmed local mechanism. Optogenetic CRH neuron inhibition reversed behavioral effects.

How the study worked

Multiple approaches to disrupt endocannabinoid signaling in rats: systemic CB1 antagonism (AM251, NESS243), endocannabinoid synthesis inhibition (LEI401), and direct PVN CB1 blockade. Outcomes: PVN Fos expression, circulating corticosterone, stress behaviors. Optogenetic CRH neuron inhibition for causal verification.

What this study cannot tell us

Animal study that may not directly translate to humans. Pharmacological agents have off-target effects. Acute disruption differs from chronic endocannabinoid deficiency. Optogenetic tools, while powerful, involve artificial neural manipulation.

How to read the evidence

Rigorous animal study using multiple converging approaches with optogenetic causal verification.

When this study was published

Published 2023.

The bigger picture

This explains why cannabis withdrawal often produces intense anxiety and stress: removing exogenous cannabinoids after the endocannabinoid system has adapted means the stress brake is temporarily weakened. It also explains the psychiatric side effects of rimonabant (a CB1 antagonist that was withdrawn as a weight-loss drug due to anxiety and depression).

Questions still open

  • Could endocannabinoid deficiency explain chronic stress and anxiety disorders in humans?
  • Would boosting endocannabinoid tone be a viable treatment for stress-related psychiatric conditions?

Common questions

Does the endocannabinoid system control stress?
Yes. This study showed that blocking endocannabinoid signaling through three different methods all triggered full stress responses in rats, including stress hormones and anxiety behaviors, even without any stressor present.
Why does cannabis withdrawal cause anxiety?
This study helps explain it: the endocannabinoid system constantly suppresses stress responses. When this system is disrupted (as during withdrawal), the stress brake is released, triggering anxiety and stress even without an external cause.

Read the original research

Disruption of tonic endocannabinoid signalling triggers cellular, behavioural and neuroendocrine responses consistent with a stress response.

British journal of pharmacology, 180(24), 3146-3159

Citation

Petrie, Gavin N; Balsevich, Georgia; Füzesi, Tamás; Aukema, Robert J; Driever, Wouter P F; van der Stelt, Mario; Bains, Jaideep S; Hill, Matthew N. (2023). Disruption of tonic endocannabinoid signalling triggers cellular, behavioural and neuroendocrine responses consistent with a stress response.. British journal of pharmacology, 180(24), 3146-3159. https://doi.org/10.1111/bph.16198

Explore the wider topic